Retour aux projets

18146.1 PFLS-LS

18146.1 PFLS-LS

Résumé

Development of novel antibiotics with additional host-protective anti-inflammatory properties against life threatening infections caused by MDR Gram-negative ESKAPE pathogens

Textes supplémentaires

Abstract

In earlier work, POL7080 was discovered; an antibiotic targeting Pseudomonas aeruginosa with a novel mode-of-action, which is currently in Phase II clinical trials. In this project, a new series of peptidomimetics with a broader spectrum of antibacterial activity against multi-drug resistant (MDR) and colistin-resistant Gram-negative ESKAPE pathogens will be studied, possessing also potential host-protective anti-inflammatory activity.

Participants

Daniel Obrecht

Wirtschaftspartner

daniel.obrecht@polyphor.com

Spexis AG CHE-108.535.251 Daniel Obrecht Hegenmattweg 125 4123 Allschwil BL CH

John A. Robinson

Kontaktperson

robinson@oci.uzh.ch

Universität Zürich Organisch-chemisches Institut John A. Robinson Winterthurerstrasse 190 8057 Zürich ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2015-12-31
Date de fin
2018-12-31
Coûts totaux approuvés
CHF 993600.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%